171 related articles for article (PubMed ID: 19329549)
1. The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia.
Abou El-Magd RM; Park HK; Kawazoe T; Iwana S; Ono K; Chung SP; Miyano M; Yorita K; Sakai T; Fukui K
J Psychopharmacol; 2010 Jul; 24(7):1055-67. PubMed ID: 19329549
[TBL] [Abstract][Full Text] [Related]
2. Comments on 'The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia'.
Hashimoto K
J Psychopharmacol; 2010 Jul; 24(7):1133-4. PubMed ID: 19939869
[No Abstract] [Full Text] [Related]
3. Potential role for astroglial D-amino acid oxidase in extracellular D-serine metabolism and cytotoxicity.
Park HK; Shishido Y; Ichise-Shishido S; Kawazoe T; Ono K; Iwana S; Tomita Y; Yorita K; Sakai T; Fukui K
J Biochem; 2006 Feb; 139(2):295-304. PubMed ID: 16452318
[TBL] [Abstract][Full Text] [Related]
4. Mutant mice and rats lacking D-amino acid oxidase.
Konno R; Hamase K; Maruyama R; Zaitsu K
Chem Biodivers; 2010 Jun; 7(6):1450-8. PubMed ID: 20564563
[TBL] [Abstract][Full Text] [Related]
5. Potential cytotoxic effect of hydroxypyruvate produced from D-serine by astroglial D-amino acid oxidase.
Chung SP; Sogabe K; Park HK; Song Y; Ono K; Abou El-Magd RM; Shishido Y; Yorita K; Sakai T; Fukui K
J Biochem; 2010 Dec; 148(6):743-53. PubMed ID: 20876609
[TBL] [Abstract][Full Text] [Related]
6. Commentary: genome-based CNS drug discovery: D-amino acid oxidase (DAAO) as a novel target for antipsychotic medications: progress and challenges.
Williams M
Biochem Pharmacol; 2009 Dec; 78(11):1360-5. PubMed ID: 19591808
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human D-amino acid oxidase.
Molla G; Sacchi S; Bernasconi M; Pilone MS; Fukui K; Polegioni L
FEBS Lett; 2006 Apr; 580(9):2358-64. PubMed ID: 16616139
[TBL] [Abstract][Full Text] [Related]
8. Is rat an appropriate animal model to study the involvement of D-serine catabolism in schizophrenia? Insights from characterization of D-amino acid oxidase.
Frattini LF; Piubelli L; Sacchi S; Molla G; Pollegioni L
FEBS J; 2011 Nov; 278(22):4362-73. PubMed ID: 21981077
[TBL] [Abstract][Full Text] [Related]
9. The discovery of fused pyrrole carboxylic acids as novel, potent D-amino acid oxidase (DAO) inhibitors.
Sparey T; Abeywickrema P; Almond S; Brandon N; Byrne N; Campbell A; Hutson PH; Jacobson M; Jones B; Munshi S; Pascarella D; Pike A; Prasad GS; Sachs N; Sakatis M; Sardana V; Venkatraman S; Young MB
Bioorg Med Chem Lett; 2008 Jun; 18(11):3386-91. PubMed ID: 18455394
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel D-amino acid oxidase inhibitors by in silico screening and their functional characterization in vitro.
Katane M; Osaka N; Matsuda S; Maeda K; Kawata T; Saitoh Y; Sekine M; Furuchi T; Doi I; Hirono S; Homma H
J Med Chem; 2013 Mar; 56(5):1894-907. PubMed ID: 23391306
[TBL] [Abstract][Full Text] [Related]
11. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia.
Tsai G; Lane HY; Yang P; Chong MY; Lange N
Biol Psychiatry; 2004 Mar; 55(5):452-6. PubMed ID: 15023571
[TBL] [Abstract][Full Text] [Related]
12. Mutant mice with reduced NMDA-NR1 glycine affinity or lack of D-amino acid oxidase function exhibit altered anxiety-like behaviors.
Labrie V; Clapcote SJ; Roder JC
Pharmacol Biochem Behav; 2009 Feb; 91(4):610-20. PubMed ID: 18940194
[TBL] [Abstract][Full Text] [Related]
13. Behavioral characterization of a mutant mouse strain lacking D-amino acid oxidase activity.
Zhang M; Ballard ME; Basso AM; Bratcher N; Browman KE; Curzon P; Konno R; Meyer AH; Rueter LE
Behav Brain Res; 2011 Feb; 217(1):81-7. PubMed ID: 20933022
[TBL] [Abstract][Full Text] [Related]
14. Effects of MK-801 on the expression of serine racemase and d-amino acid oxidase mRNAs and on the D-serine levels in rat brain.
Hashimoto A; Yoshikawa M; Andoh H; Yano H; Matsumoto H; Kawaguchi M; Oka T; Kobayashi H
Eur J Pharmacol; 2007 Jan; 555(1):17-22. PubMed ID: 17109841
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties.
Adage T; Trillat AC; Quattropani A; Perrin D; Cavarec L; Shaw J; Guerassimenko O; Giachetti C; Gréco B; Chumakov I; Halazy S; Roach A; Zaratin P
Eur Neuropsychopharmacol; 2008 Mar; 18(3):200-14. PubMed ID: 17681761
[TBL] [Abstract][Full Text] [Related]
16. D-Amino acids in the brain and mutant rodents lacking D-amino-acid oxidase activity.
Yamanaka M; Miyoshi Y; Ohide H; Hamase K; Konno R
Amino Acids; 2012 Nov; 43(5):1811-21. PubMed ID: 22892863
[TBL] [Abstract][Full Text] [Related]
17. Engineering the substrate specificity of porcine kidney D-amino acid oxidase by mutagenesis of the "active-site lid".
Setoyama C; Nishina Y; Mizutani H; Miyahara I; Hirotsu K; Kamiya N; Shiga K; Miura R
J Biochem; 2006 May; 139(5):873-9. PubMed ID: 16751595
[TBL] [Abstract][Full Text] [Related]
18. A series of D-amino acid oxidase inhibitors specifically prevents and reverses formalin-induced tonic pain in rats.
Gong N; Gao ZY; Wang YC; Li XY; Huang JL; Hashimoto K; Wang YX
J Pharmacol Exp Ther; 2011 Jan; 336(1):282-93. PubMed ID: 20952482
[TBL] [Abstract][Full Text] [Related]
19. Effect of risperidone on plasma d-serine concentration in rats post-administered with d-serine.
Onozato M; Nakazawa H; Hakariya H; Shishikura M; Nagashima C; Ishimaru K; Sakamoto T; Iizuka H; Ichiba H; Fukushima T
Life Sci; 2016 Aug; 158():98-103. PubMed ID: 27352936
[TBL] [Abstract][Full Text] [Related]
20. Indispensable but insufficient role of renal D-amino acid oxidase in chiral inversion of NG-nitro-D-arginine.
Xin YF; Li X; Hao B; Gong N; Sun WQ; Konno R; Wang YX
Chem Biodivers; 2010 Jun; 7(6):1413-23. PubMed ID: 20564560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
